Amgen edges higher to $347.82 as it joins HHS roundtable on clinical trial access

Traders Union
All News
Companies
Amgen rises 0.94% today to $347.82

Highlights

AMGN sustains a strong bullish trend, trading well above short-, medium-, and long-term support levels.
Momentum indicators remain positive with strong buy signals, although overbought conditions and weak ADX suggest caution as momentum may near exhaustion.
The expected price range for the coming week is $340.00 to $361.00, with consolidation likely and a high probability of further upside unless support at $341.75 fails.

Bullish trend holds as price stays above key support levels

AMGN is trading at $347.82, positioned well above its SMA-20 at $341.75, SMA-50 at $340.03, and SMA-200 at $332.18, indicating ongoing short-, medium-, and long-term bullish trends. The Ichimoku Kijun on D1 stands at $339.72, which acts as immediate support. Near-term support lies at $341.75 (SMA-20), with key support at $332.18 (SMA-200), while immediate resistance is at $351.54 (SMA-100) and $339.72 (Ichimoku Kijun), with the next resistance clustered at $351.54 (SMA-100).

Upward momentum persists as rally nears resistance and overbought zone

Momentum remains positive as MACD on D1 signals a strong buy, supported by bullish readings from RSI and Stoch RSI in neutral-to-buy territory, while ADX reflects a weak trend environment at 10.04. BBP is firmly overbought at 1.43 on D1, confirming ongoing buyer dominance, but CCI and Awesome Oscillator both remain neutral, suggesting that momentum could be nearing exhaustion. AMGN has risen $10.45 (3.09%) over the past week, moving from a previous weekly close of $337.37 to current levels and now sits at the very top of its weekly range near resistance. Weekly volatility stands at 4.58%. The tone for the week is a strong rally with consistent upward momentum and little sign of profit-taking.

Probability favors upside as consolidation or breakout scenarios develop

For the coming week, the expected trading range is $340.00 to $361.00, keeping well within 10% of the current price and aligning with the recent trend highs while remaining far above the 52-week low of $269.77 and beneath the 52-week high of $391.29. The probability of a price increase is high (more than 80%), supported by buy signals in MA-50 (W1), RSI (W1), and MACD (W1), making a downside move much less likely. The baseline scenario sees AMGN consolidating between $340.00 and $355.00. A bullish scenario could see a breakout above $355.00 toward $361.00 if momentum and weekly buying pressure persist. Conversely, a bearish scenario entails a slip below $341.75, potentially pulling back toward $332.18 key support.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Amgen demonstrated a bullish outlook, supported by positive technical momentum and ongoing corporate investments. As the current environment evolves, investors should watch for shifts in institutional positioning or new developments that could influence the prevailing upside scenario.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.